NEW ORLEANS, July 14, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 28, 2017 to file lead plaintiff applications in a securities class action lawsuit against Mattel, Inc. (Nasdaq:MAT), if they purchased the Company’s securities between October 20, 2016 and April 20, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
Get Help
Mattel investors should visit us at https://www.claimsfiler.com/cases/view-mattel-inc-securities-litigation-1 or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Mattel and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On October 19, 2016, Mattel announced positive results for Q3 2016. However, the Company failed to disclose that it had issued an excessive level of inventory to its retailers which, although temporarily inflating revenue, required the Company to later make significant sales adjustments and discounts to clear the excess product and ultimately resulted in a material negative impact on performance. As a result, on April 20, 2017, Mattel revealed dismal financial results for Q1 2017, well below Wall Street consensus estimates.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 



